VRNA - ベロナ・ファ―マ (Verona Pharma plc)

VRNAのニュース

   Verona Pharma : 2021 AGM Notice and Proxy Statement | MarketScreener  2021/03/21 11:05:02 MarketScreener
Verona Pharma plc NOTICE & PROXY STATEMENT Annual General Meeting of Shareholders April 27, 2021 1:00 p.m. … | March 21, 2021
   Verona Pharma to Present at H.C. Wainwright Global Life Sciences Virtual Conference | MarketScreener  2021/03/01 07:00:02 MarketScreener
LONDON and RALEIGH, N.C., March 01, 2021 -- Verona Pharma plc , a clinical-stage biopharmaceutical company focused on respiratory diseases, announces that David Zaccardelli, Chief Executive… | March 1, 2021
   Verona Pharma Earnings and Growth Analysis : Stock market Insights & financial analysis  2021/02/25 07:04:00 Stock Market Daily
Verona Pharma announce their quarterly, annual earnings. See the latest EPS estimates. Listen to the conference call and remind yourself by…
   Verona Pharma to Report Fourth Quarter and Full Year 2020 Financial Results and Provide Corporate Update - Stocks News Feed  2021/02/18 07:00:00 Stocks News Feed
LONDON and RALEIGH, N.C., Feb. 18, 2021 (GLOBE NEWSWIRE) — Verona Pharma plc (NASDAQ:VRNA) (“Verona Pharma”), a clinical-stage biopharmaceutical company focused on respiratory diseases, announces that it will report its financial results for the fourth quarter and full year ended December 31, 2020 on Thursday, February 25, 2021 and host an investment community conference call… Read More »Verona Pharma to Report Fourth Quarter and Full Year 2020 Financial Results and Provide Corporate Update
   Financial Comparison: Zosano Pharma (NASDAQ:ZSAN) and Verona Pharma (NASDAQ:VRNA)  2021/02/12 10:57:23 Modern Readers
Zosano Pharma (NASDAQ:ZSAN) and Verona Pharma (NASDAQ:VRNA) are both small-cap medical companies, but which is the superior investment? We will compare the two businesses based on the strength of their valuation, risk, analyst recommendations, dividends, earnings, profitability and institutional ownership. Valuation & Earnings This table compares Zosano Pharma and Verona Pharma’s top-line revenue, earnings per […]
   Verona Pharma : 2021 AGM Notice and Proxy Statement | MarketScreener  2021/03/21 11:05:02 MarketScreener
Verona Pharma plc NOTICE & PROXY STATEMENT Annual General Meeting of Shareholders April 27, 2021 1:00 p.m. … | March 21, 2021
   Verona Pharma to Present at H.C. Wainwright Global Life Sciences Virtual Conference | MarketScreener  2021/03/01 07:00:02 MarketScreener
LONDON and RALEIGH, N.C., March 01, 2021 -- Verona Pharma plc , a clinical-stage biopharmaceutical company focused on respiratory diseases, announces that David Zaccardelli, Chief Executive… | March 1, 2021
   Verona Pharma Earnings and Growth Analysis : Stock market Insights & financial analysis  2021/02/25 07:04:00 Stock Market Daily
Verona Pharma announce their quarterly, annual earnings. See the latest EPS estimates. Listen to the conference call and remind yourself by…
   Verona Pharma to Report Fourth Quarter and Full Year 2020 Financial Results and Provide Corporate Update - Stocks News Feed  2021/02/18 07:00:00 Stocks News Feed
LONDON and RALEIGH, N.C., Feb. 18, 2021 (GLOBE NEWSWIRE) — Verona Pharma plc (NASDAQ:VRNA) (“Verona Pharma”), a clinical-stage biopharmaceutical company focused on respiratory diseases, announces that it will report its financial results for the fourth quarter and full year ended December 31, 2020 on Thursday, February 25, 2021 and host an investment community conference call… Read More »Verona Pharma to Report Fourth Quarter and Full Year 2020 Financial Results and Provide Corporate Update
   Financial Comparison: Zosano Pharma (NASDAQ:ZSAN) and Verona Pharma (NASDAQ:VRNA)  2021/02/12 10:57:23 Modern Readers
Zosano Pharma (NASDAQ:ZSAN) and Verona Pharma (NASDAQ:VRNA) are both small-cap medical companies, but which is the superior investment? We will compare the two businesses based on the strength of their valuation, risk, analyst recommendations, dividends, earnings, profitability and institutional ownership. Valuation & Earnings This table compares Zosano Pharma and Verona Pharma’s top-line revenue, earnings per […]
   Verona Pharma to Present at H.C. Wainwright Global Life Sciences Virtual Conference | MarketScreener  2021/03/01 07:00:02 MarketScreener
LONDON and RALEIGH, N.C., March 01, 2021 -- Verona Pharma plc , a clinical-stage biopharmaceutical company focused on respiratory diseases, announces that David Zaccardelli, Chief Executive… | March 1, 2021
   Verona Pharma Earnings and Growth Analysis : Stock market Insights & financial analysis  2021/02/25 07:04:00 Stock Market Daily
Verona Pharma announce their quarterly, annual earnings. See the latest EPS estimates. Listen to the conference call and remind yourself by…
   Verona Pharma to Report Fourth Quarter and Full Year 2020 Financial Results and Provide Corporate Update - Stocks News Feed  2021/02/18 07:00:00 Stocks News Feed
LONDON and RALEIGH, N.C., Feb. 18, 2021 (GLOBE NEWSWIRE) — Verona Pharma plc (NASDAQ:VRNA) (“Verona Pharma”), a clinical-stage biopharmaceutical company focused on respiratory diseases, announces that it will report its financial results for the fourth quarter and full year ended December 31, 2020 on Thursday, February 25, 2021 and host an investment community conference call… Read More »Verona Pharma to Report Fourth Quarter and Full Year 2020 Financial Results and Provide Corporate Update
   Financial Comparison: Zosano Pharma (NASDAQ:ZSAN) and Verona Pharma (NASDAQ:VRNA)  2021/02/12 10:57:23 Modern Readers
Zosano Pharma (NASDAQ:ZSAN) and Verona Pharma (NASDAQ:VRNA) are both small-cap medical companies, but which is the superior investment? We will compare the two businesses based on the strength of their valuation, risk, analyst recommendations, dividends, earnings, profitability and institutional ownership. Valuation & Earnings This table compares Zosano Pharma and Verona Pharma’s top-line revenue, earnings per […]
   Asthma & COPD Market - AstraZeneca, Novartis AG, GlaxoSmithKline plc, Merck & Co., Verona Pharma plc,, Regeneron Pharmaceuticals, Inc., GlaxoSmithKline plc, and Boehringer Ingelheim GmbH.  2021/02/11 15:18:39 OpenPR
The Asthma & COPD market demand is anticipated to flourish during the forecast period 2020-2027. The report offers information related to import and export, along with the current business chain in the market at the global level. This report provides

calendar